WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2018032057) VIRAL VACCINES
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.:    WO/2018/032057    International Application No.:    PCT/AU2017/050879
Publication Date: 22.02.2018 International Filing Date: 18.08.2017
Chapter 2 Demand Filed:    03.04.2018    
IPC:
A61K 35/76 (2015.01), A61K 31/7088 (2006.01), A61P 31/12 (2006.01)
Applicants: SEMENTIS LIMITED [AU/AU]; 9 Sing Crescent Berwick, Victoria 3806 (AU)
Inventors: HOWLEY, Paul; (AU)
Agent: DAVIES COLLISON CAVE PTY LTD; 1 Nicholson Street Melbourne, Victoria 3000 (AU)
Priority Data:
2016903295 19.08.2016 AU
Title (EN) VIRAL VACCINES
(FR) VACCINS CONTRE DES VIRUS
Abstract: front page image
(EN)The present invention relates to a composition for raising an immune response in animal which decreases the risk of chikungunya and smallpox infection, Zika virus and smallpox infection, and/or chikungunya, Zika virus and smallpox infection. The composition comprises a pharmaceutically acceptable carrier and an attenuated poxvirus, wherein the poxvirus genome comprises a nucleic acid sequence encoding the 26S subgenomic polyprotein of chikungunya virus and/or the PrME of Zika virus.
(FR)La présente invention concerne une composition visant à stimuler la réponse immunitaire chez l'animal et ainsi diminuer le risque d'une infection par le virus Chikungunya et par le virus de la variole, d'une infection par le virus Zika et par le virus de la variole et/ou d'une infection par le virus Chikungunya, par le virus Zika et par le virus de la variole. La composition comprend un support pharmaceutiquement acceptable et un poxvirus atténué, le génome du poxvirus comprenant une séquence d'acide nucléique codant pour la polyprotéine subgénomique 26S du virus Chikungunya et/ou les protéines PrM-Env du virus Zika.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)